Browse by Poster Title

• U
• P-118
  Understanding Oral Anticoagulant Preferences of Patients with Atrial Fibrillation in China and Willingness-to-pay: Evidence from a Discrete Choice Experiment
  Favorite
• P-560
  Urban Prevalence of Multiple Sclerosis in China: A Population-based Study in Six Provinces
  Favorite
• P-205
  Use and Performance of Brighton Collaboration Case Definitions in Low-middle Income Settings
  Favorite
• P-427
  Use of and Adherence to Bisphosphonates in Elderly Patients with Complex Health Needs: An Analysis of UK Primary Care Records
  Favorite
• P-204
  Use of Beta Blockers and Death from Breast Cancer in New Zealand Breast Cancer Patients
  Favorite
• P-616
  Use of High-dimensional Propensity Scores (hdPS) in a Japanese National Claims Database
  Favorite
• P-497
  Use of Knowledge Bases in Medical Education: Medical Students’ Perspective
  Favorite
• P-617
  Use of Natural Language Processed Clinical Notes in an Electronic Health Record (EHR) to Characterize Adverse Events of Mood Disorders
  Favorite
• P-245
  Use of Non-insulin Antidiabetic Drugs in Children and Young Adults – a Scandinavian Drug Utilization Study from 2010-2019
  Favorite
• P-618
  Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
  Favorite
• P-191
  Use of Potentially Inapropriate Medicines by Elderly People in Primary Care of the Unified Health System (SUS) in Brazil
  Favorite
• P-475
  Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
  Favorite
• P-617
  Use of Renin-angiotensin-aldosterone System Inhibitors and the Risk of Acute Pancreatitis
  Favorite
• P-377
  Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
  Favorite
• P-141
  Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
  Favorite
• P-573
  Using Negative Control Outcomes to Assess the Comparability of Treatment Groups Among Postmenopausal Women Switching Osteoporosis Therapy
  Favorite
• P-618
  Using Structural Topic Modelling to Reveal Patterns in Reports on Opioid Drugs in a Pharmacovigilance Database
  Favorite
• P-389
  Utilisation and Safety of Glycopyrronium Bromide (GPB) Oral Solution for the Treatment of Sialorrhoea in Children <18 Years in the UK
  Favorite
• P-625
  Utilization and Long-term Persistence of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease
  Favorite
• P-472
  Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy
  Favorite
• P-414
  Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany
  Favorite
• P-634
  Utilization Pattern of Antipsychotics in Patients with Dementia
  Favorite
• P-409
  Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
  Favorite
• P-357
  Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
  Favorite
• P-313
  Utilizing a Structured Benefit-risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder
  Favorite